What's in the water? Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


What's in the water? Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Treat Rev. 1995 Mar/Apr;(no 17):4-5. Unique Identifier : AIDSLINE AIDS/95700322


Abstract: Cryptosporidiosis is a protozoal infection that can come from water, or be spread from person to person. Individual protozoa are very resistant to the environment and disinfectants. How cryptosporidium causes infection is unknown, but it is known that large adult animals that commonly become infected do not get sick; small animals such as mice do not get symptomatic infection so there are no disease models to study in the lab. It is not known how many people are carrying the organism, however, in people with AIDS, 10 to 20 percent appear to be infected and testing for cryptosporidiosis is nearly impossible. It is also unknown what the immune system responds to in order to make antibodies to cryptosporidium. There have been outbreaks of cryptosporidiosis in the water supply of cities with public water filtering systems, such as Milwaukee in 1993. Boiling water for at least 1 minute kills the cryptosporidial oocysts if any exist, and while some bottled water claims to be cryptosporidium free, no data exist to prove it. No really good treatment exists for cryptosporidiosis, but Azithromycin is better absorbed than other drugs studied; it can be obtained directly from Pfizer through their compassionate use program. A new study using IGX is being conducted using chicken immunoglobulins which fight cryptosporidiosis. Participants drink irradiated eggnog five times per day. Participants must be HIV positive, have cryptosporidiosis, and not have other intestinal infection. The Network can be contacted for more information on this study.
Keywords: Animal Antiprotozoal Agents/THERAPEUTIC USE Azithromycin/THERAPEUTIC USE *Cryptosporidiosis/COMPLICATIONS/DRUG THERAPY/PARASITOLOGY/ THERAPY Disease Models, Animal Human HIV Seropositivity/COMPLICATIONS Immunoglobulins/THERAPEUTIC USE Immunotherapy *Water Microbiology NEWSLETTER ARTICLEKWDanimalantiprotozoalagents/therapeuticuseazithromycin/therapeuticuseKWDcryptosporidiosis/complications/drugtherapy/parasitology/therapydiseasemodels,animalhumanhivseropositivity/complicationsimmunoglobulins/therapeuticuseimmunotherapyKWDwatermicrobiologynewsletterarticle
951030
M95A0924

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .